Skip to content
10-Q

Quarterly Report

Adamas Pharmaceuticals, Inc.

0001328143-21-000071

← back to feed
Filed
Aug 9, 2021 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2021 · Jul 30, 2021 45.6M sh
Shares Diluted Q2 2021 · Jun 30, 2021 45.46M sh
Shares Diluted Q2 2021 · Jun 30, 2021 40.34M sh
Shares Diluted Q2 2021 · Jun 30, 2020 28.19M sh
Shares Diluted Q2 2021 · Jun 30, 2020 28.11M sh
Capex Q2 2021 · Jun 30, 2021 $30K
Capex Q2 2021 · Jun 30, 2020 $0
Operating Cash Flow Q2 2021 · Jun 30, 2021 −$30.24M
Operating Cash Flow Q2 2021 · Jun 30, 2020 −$29.53M
Long Term Debt Q2 2021 · Jun 30, 2021 $125.54M
Long Term Debt Q2 2021 · Dec 31, 2020 $126.31M
Short Term Debt Q2 2021 · Jun 30, 2021 $4.17M
Short Term Debt Q2 2021 · Dec 31, 2020 $3.66M
Short Term Investments Q2 2021 · Jun 30, 2021 $2.57M
Short Term Investments Q2 2021 · Dec 31, 2020 $11.71M
Cash And Equivalents Q2 2021 · Jun 30, 2021 $88.8M
Cash And Equivalents Q2 2021 · Dec 31, 2020 $71.66M
Stockholders Equity Q2 2021 · Jun 30, 2021 −$4.03M
Stockholders Equity Q2 2021 · Mar 31, 2021 $5.94M
Stockholders Equity Q2 2021 · Dec 31, 2020 −$49.98M
Stockholders Equity Q2 2021 · Jun 30, 2020 −$24.41M
Stockholders Equity Q2 2021 · Mar 31, 2020 −$15.85M
Stockholders Equity Q2 2021 · Dec 31, 2019 −$893K
Current Liabilities Q2 2021 · Jun 30, 2021 $21.82M
Current Liabilities Q2 2021 · Dec 31, 2020 $34.87M
Total Liabilities Q2 2021 · Jun 30, 2021 $154.68M
Total Liabilities Q2 2021 · Dec 31, 2020 $170.01M
Current Assets Q2 2021 · Jun 30, 2021 $115.66M
Current Assets Q2 2021 · Dec 31, 2020 $111.74M
Total Assets Q2 2021 · Jun 30, 2021 $150.64M
Total Assets Q2 2021 · Dec 31, 2020 $120.03M
Eps Diluted Q2 2021 · Jun 30, 2021 −$0.27
Eps Diluted Q2 2021 · Jun 30, 2021 −$0.62
Eps Diluted Q2 2021 · Jun 30, 2020 −$0.37
Eps Diluted Q2 2021 · Jun 30, 2020 −$0.97
Eps Basic Q2 2021 · Jun 30, 2021 −$0.27
Eps Basic Q2 2021 · Jun 30, 2021 −$0.62
Eps Basic Q2 2021 · Jun 30, 2020 −$0.37
Eps Basic Q2 2021 · Jun 30, 2020 −$0.97
Sga Expense Q2 2021 · Jun 30, 2021 $29.15M
Sga Expense Q2 2021 · Jun 30, 2021 $55.79M
Sga Expense Q2 2021 · Jun 30, 2020 $23.18M
Sga Expense Q2 2021 · Jun 30, 2020 $47.73M
Rd Expense Q2 2021 · Jun 30, 2021 $1.45M
Rd Expense Q2 2021 · Jun 30, 2021 $3.26M
Rd Expense Q2 2021 · Jun 30, 2020 $2.55M
Rd Expense Q2 2021 · Jun 30, 2020 $5.02M
Net Income Q2 2021 · Jun 30, 2021 −$12.34M
Net Income Q2 2021 · Jun 30, 2021 −$24.92M
Net Income Q2 2021 · Mar 31, 2021 −$12.57M
Net Income Q2 2021 · Jun 30, 2020 −$10.57M
Net Income Q2 2021 · Jun 30, 2020 −$27.21M
Net Income Q2 2021 · Mar 31, 2020 −$16.65M
Operating Income Q2 2021 · Jun 30, 2021 −$9.16M
Operating Income Q2 2021 · Jun 30, 2021 −$18.68M
Operating Income Q2 2021 · Jun 30, 2020 −$7.31M
Operating Income Q2 2021 · Jun 30, 2020 −$20.42M
Cost Of Revenue Q2 2021 · Jun 30, 2021 $527K
Cost Of Revenue Q2 2021 · Jun 30, 2021 $912K
Cost Of Revenue Q2 2021 · Jun 30, 2020 $381K
Cost Of Revenue Q2 2021 · Jun 30, 2020 $953K
Revenue Q2 2021 · Jun 30, 2021 $21.97M
Revenue Q2 2021 · Jun 30, 2021 $41.28M
Revenue Q2 2021 · Jun 30, 2020 $18.79M
Revenue Q2 2021 · Jun 30, 2020 $33.28M